Cargando…

D-dimer Testing in Pulmonary Embolism with a Focus on Potential Pitfalls: A Narrative Review

D-dimer is a multifaceted biomarker of concomitant activation of coagulation and fibrinolysis, which is routinely used for ruling out pulmonary embolism (PE) and/or deep vein thrombosis (DVT) combined with a clinical pretest probability assessment. The intended use of the tests depends largely on th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wauthier, Loris, Favresse, Julien, Hardy, Michaël, Douxfils, Jonathan, Le Gal, Grégoire, Roy, Pierre-Marie, van Es, Nick, Ay, Cihan, ten Cate, Hugo, Vander Borght, Thierry, Dupont, Michaël V., Lecompte, Thomas, Lippi, Giuseppe, Mullier, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689068/
https://www.ncbi.nlm.nih.gov/pubmed/36428830
http://dx.doi.org/10.3390/diagnostics12112770
Descripción
Sumario:D-dimer is a multifaceted biomarker of concomitant activation of coagulation and fibrinolysis, which is routinely used for ruling out pulmonary embolism (PE) and/or deep vein thrombosis (DVT) combined with a clinical pretest probability assessment. The intended use of the tests depends largely on the assay used, and local guidance should be applied. D-dimer testing may suffer from diagnostic errors occurring throughout the pre-analytical, analytical, and post-analytical phases of the testing process. This review aims to provide an overview of D-dimer testing and its value in diagnosing PE and discusses the variables that may impact the quality of its laboratory assessment.